<?xml version="1.0" encoding="UTF-8"?>
<p>The patient received 100 mg/d aspirin, 180 mg/d ticagrelor, and 40 mg/d atorvastatin orally for myocardial infarction after percutaneous coronary intervention. The patient had an uneventful hospitalization and was discharged with a suggestion of avoiding phloroglucinol. During the 6-month follow-up, the patient did not experience chest pain. A detailed timeline from the onset of symptoms in the patient to his discharge is provided (
 <xref rid="T1" ref-type="table">Table 1</xref>).
</p>
